• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVT
Click for more information
0.00% 2.7¢

INVENTIS LIMITED

Market Cap $2.063M  ! watchlist Created with Sketch. Add to my watchlist
Industrials

Inventis Limited is an Australia-based diversified company. The Company is involved in... Inventis Limited is an Australia-based diversified company. The Company is involved in the designing, manufacturing, selling and marketing of products and services. The Company has three divisions: Technology, Furniture and Rugged solutions. Technology division consists of six main brands: Impart, PNE, Hazavoid, Safezone, Inventis International and ECD. The division is a provider of contract design services for original equipment manufacturers and specializing in electronic control solutions. Furniture division features five brands: Gregory Commercial Furniture, Workstations, Bassets Furniture, Bevisco and Winya. The division provides a comprehensive suite of furniture solutions tailored to modern workplace needs. The Rugged solutions division consists of Opentec, which is an original rugged computer specialist. The Rugged solutions division offers from semi-rugged to fully rugged solutions for general purpose and field-based applications to military rugged models for defense roles.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVT
Ann: FY24 Annual Report to shareholders 		27/09/24 0 80
27/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  80 
IVT
News: IVT Inventis Says Ivt Company Sales To 31 March 24 Ytd -12.5% YoY 		26/09/24 13 1.9K
26/09/24 Last post  chairs Comments Created with Sketch.  13  Views Created with Sketch.  1.9K 
IVT
Ann: Appendix 4G 		20/09/24 0 101
20/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  101 
IVT
Ann: Preliminary Final Report 		30/08/24 0 128
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  128 
IVT
Ann: Becoming a substantial holder 		06/08/24 0 171
06/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  171 
IVT
Ann: Ceasing to be a substantial holder 		06/08/24 0 117
06/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  117 
IVT
News: IVT Inventis Posts Q4 Sales Of A$3.4 Million 		31/07/24 0 73
31/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  73 
IVT
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		31/07/24 0 166
31/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  166 

See All Discussions arrow Created with Sketch.

Timeline

FY24 Annual Report to shareholders
27 Sep 16:46
 
Appendix 4G
20 Sep 12:33
 
Preliminary Final Report
30 Aug 15:49
 
Becoming a substantial holder
06 Aug 15:46
 
Ceasing to be a substantial holder
06 Aug 15:43
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 15:25
 
View More arrow Created with Sketch.

Featured News

NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
NEWS High-grade gold discovery at Didievi Project: First drill results reveal impressive 33m intercept at 2.4g/t
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
NEWS Most viewed thread today: Rio Tinto confirms approach to Arcadium Lithium
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
(20min delay)
Last
2.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.063M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 322550 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 489044 1
View Market Depth
Last trade - 10.04am 08/10/2024 (20 minute delay) ?
IVT (ASX) Chart

Top Stories

Elixir winds up QLD operations with five of six zones flowing gas – but shares plummet -50%

Elixir Energy (ASX:EXR) is all but guaranteed to become a future gas producer with 5 of 6 zones part of the Daydream-2 well flowing gas.
Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions Litchfield Minerals Ltd has grown its copper, base metals and precious metals portfolio in the Northern Territory with a suite of new projects
Madagascar mining minister expresses support for Akora's Bekisopa iron ore project Akora Resources (ASX:AKO) has reported the mining minister of Madagascar, Dr. Olivier Rakotomalala, expressed his support for the company's Bekisopa iron ore project in late September.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Droneshield shares move up on $13.5M US govt contract Droneshield Ltd has seen its shares rise by more than 4% on news of a significant defense contract with the US government

Featured News

NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS Second consecutive quarter of record revenue driven by strong sales growth in market-leading medical products!
right-arrow Created with Sketch.
NEWS Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now
right-arrow Created with Sketch.
NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.